Alfresa
Dược phẩm và sản phẩm y tế dành cho nhà cung cấp dịch vụ chăm sóc sức khỏe
Alfresa phân phối thuốc theo toa, sản phẩm y tế và vật tư chẩn đoán. Mạng lưới của nó phục vụ các hiệu thuốc và cơ sở chăm sóc sức khỏe trên khắp Nhật Bản.
- Type
- distributor (our classification of the record, not a statement by the company)
- Role
- Distributor
- Location
- Tokyo, Japan
- Website
- alfresa.com
- Categories
- Sản xuất dược phẩm, Vật tư y tế và chăm sóc sức khỏe
- Markets
- Nhật Bản
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-04 Mail server of the company domain
- domain-registered (green), checked 2026-08-04 Domain registry record
- sanctions-clear (green), checked 2026-08-04 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- debarment-clear (green), checked 2026-08-04 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- fda-registered (green), checked 2026-08-04 FDA
- web-presence-since (green), checked 2026-08-03 Internet Archive (Wayback)
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)